share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E

艾伯维公司 | 4：持股变动声明-董事 Quaggin Susan E
美股sec公告 ·  05/07 18:36
Moomoo AI 已提取核心信息
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
2024年5月3日，与艾伯维公司 [ABBV] 关联的苏珊·夸金免费获得了1,322股普通股。该交易于同日完成，使Quaggin在该公司的直接持股量增加到1,322股。授予的每股股票面值为0.01美元，赠款表示直接收购该制药公司的股权。
2024年5月3日，与艾伯维公司 [ABBV] 关联的苏珊·夸金免费获得了1,322股普通股。该交易于同日完成，使Quaggin在该公司的直接持股量增加到1,322股。授予的每股股票面值为0.01美元，赠款表示直接收购该制药公司的股权。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息